RA Capital Nexus Fund II, L.P.
CIK 0001825376Director10% Owner
Filings
5
Latest Mar 27, 2024
Issuers covered
5
Showing
5 of 5
Page 1
Issuers
Companies where RA Capital Nexus Fund II, L.P. has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| SPRY | ARS Pharmaceuticals, Inc. | 1 | Mar 27, 2024 |
| ICVX | Icosavax, Inc. | 1 | Feb 20, 2024 |
| JANX | Janux Therapeutics, Inc. | 1 | Mar 6, 2024 |
| LENZ | LENZ Therapeutics, Inc. | 1 | Mar 25, 2024 |
| PEPG | PepGen Inc. | 1 | Feb 13, 2024 |
All filings
5 Form 4 / 4-A filings, newest first
| Filed | Issuer | Top transaction | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Mar 27, 2024 | SPRYARS Pharmaceuticals, Inc. | P | 505,954 | $9.79 | $4,953,290 | |
| Mar 25, 2024 | LENZLENZ Therapeutics, Inc. | P | 933,038 | $15.03 | $14,023,561 | |
| Mar 6, 2024 | JANXJanux Therapeutics, Inc. | Holdings only | — | — | — | |
| Feb 20, 2024 | ICVXIcosavax, Inc. | U | 5,543 | — | — | |
| Feb 13, 2024 | PEPGPepGen Inc. | P | 2,557,593 | $10.64 | $27,212,790 |
Showing 1–5 of 5
Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.